Enzo Biochem has appointed Rebecca Fischer to its board of directors, effective immediately. Her appointment as an independent director follows a process as part of the company's focus on board compositions, refreshment, and diversity. Fisher's appointment, Enzo said, will be a valuable contribution to its women's health business. She replaces Gregory Bortz who retired from the board. Dov Perlysky, who has been on the board since 2012, will replace Bortz as lead independent director of Enzo.
Fisher has been appointed to Enzo's audit, compensation, and nominating/governance committees and will be chair of the audit committee. She is currently CFO of Bellevue Hospital. She began her career there in 2003 and was promoted to deputy CFO in 2016 before becoming CFO in 2017.